Key Source of Loss of CAR T Cell Potency Identified
Dana-Farber Cancer Institute
Discovery may help design drugs that prevent T-cell therapies from losing their efficacy over time
Microfluidic device uses lactate levels in circulating single cells as a biomarker to detect and classify active tumor cells